Advanced MRI
Combinostics demonstrated solutions for neurodegenerative disorder care pathways at Advanced MRI.
combinostics.comCrawled Nov 18, 2026
Combinostics demonstrated solutions for neurodegenerative disorder care pathways at Advanced MRI.
A study published by Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring evaluates cCOG, a web-based cognitive test tool for detecting neurodegenerative disorders compared with standard tests. Jyrki Lötjönen and Juha Koikkalainen co-author.
Study results show that the web-based cognitive test tool cCOG is comparable to traditional neuropsychology tests in detecting MCI and dementias.
The eBook explains how AI technology applied to MRI can assist clinicians in diagnosing dementia.
The webinar features Frederik Barkhof, Lennart Thurfjell, and Jyrki Lötjönen discussing quantitative MRI assessments.
The white paper describes methods for assessing automated image segmentation and analysis using cMRI.
Combinostics presented the cNeuro suite at the 14th Radiologie Kongress Ruhr (RKR).
Combinostics discussed the cNeuro suite’s role in neurological disorder patient care pathways at AAIC 2022.
Combinostics presented at the 2022 AAN Annual Meeting on how the cNeuro suite supports neurological patient care.
At ECTRIMS 2022, Combinostics showcased the cNeuro suite’s support for multiple sclerosis patient care.
Combinostics offers career opportunities focused on improving lives with Alzheimer’s and neurological disorders.
The blog post introduces Erik Post, Group CFO of Combinostics, and his passion for healthcare technology.
Greg Kingston joins the Combinostics leadership team as Chief Marketing Officer (CMO). He has more than a decade of experience in the medical imaging software domain and a focus in AI-based technology.
The blog post profiles Jin Gong, an Imaging Scientist at Combinostics, and her background in Alzheimer’s disease research.
The blog post highlights Peter Ngum, a Clinical Application Specialist at Combinostics, and his professional experience.
The blog post introduces Richard Hausmann, CEO of Combinostics, and his professional background.
Richard Hausmann has been named Chief Executive Officer of Combinostics. Most recently, he served as President and CEO of Elekta AB, a cancer care company.
Combinostics uses AI technology to address challenges in neurological disorder patient care.